Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond
Identifieur interne : 000247 ( Main/Corpus ); précédent : 000246; suivant : 000248Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond
Auteurs : Christine Klein ; Susanne A. Schneider ; Anthony E. LangSource :
- Movement Disorders [ 0885-3185 ] ; 2009-10-30.
English descriptors
- KwdEn :
Abstract
In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22675
Links to Exploration step
ISTEX:E0892A43430A164AA0D1E041631E2BF933EB6DEELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title><author><name sortKey="Klein, Christine" sort="Klein, Christine" uniqKey="Klein C" first="Christine" last="Klein">Christine Klein</name><affiliation><mods:affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name><affiliation><mods:affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</mods:affiliation></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name><affiliation><mods:affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E0892A43430A164AA0D1E041631E2BF933EB6DEE</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22675</idno><idno type="url">https://api.istex.fr/document/E0892A43430A164AA0D1E041631E2BF933EB6DEE/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000247</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title><author><name sortKey="Klein, Christine" sort="Klein, Christine" uniqKey="Klein C" first="Christine" last="Klein">Christine Klein</name><affiliation><mods:affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name><affiliation><mods:affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</mods:affiliation></affiliation></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name><affiliation><mods:affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-10-30">2009-10-30</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2042">2042</biblScope><biblScope unit="page" to="2058">2058</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">E0892A43430A164AA0D1E041631E2BF933EB6DEE</idno><idno type="DOI">10.1002/mds.22675</idno><idno type="ArticleID">MDS22675</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>PARK</term><term>Parkinson</term><term>classification</term><term>dystonia</term><term>genetics</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Christine Klein MD</name><affiliations><json:string>Department of Neurology, University of Lübeck, Lübeck, Germany</json:string><json:string>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</json:string></affiliations></json:item><json:item><name>Susanne A. Schneider MD, PhD</name><affiliations><json:string>Department of Neurology, University of Lübeck, Lübeck, Germany</json:string><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</json:string></affiliations></json:item><json:item><name>Anthony E. Lang MD, FRCPC</name><affiliations><json:string>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>PARK</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>genetics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dystonia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>classification</value></json:item></subject><articleId><json:string>MDS22675</json:string></articleId><language><json:string>eng</json:string></language><abstract>In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society</abstract><qualityIndicators><score>7.76</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>1547</abstractCharCount><pdfWordCount>10393</pdfWordCount><pdfCharCount>73567</pdfCharCount><pdfPageCount>17</pdfPageCount><abstractWordCount>230</abstractWordCount></qualityIndicators><title>Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title><genre><json:string>review-article</json:string></genre><host><volume>24</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>17</total><last>2058</last><first>2042</first></pages><issn><json:string>0885-3185</json:string></issn><issue>14</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2009</publicationDate><copyrightDate>2009</copyrightDate><doi><json:string>10.1002/mds.22675</json:string></doi><id>E0892A43430A164AA0D1E041631E2BF933EB6DEE</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/E0892A43430A164AA0D1E041631E2BF933EB6DEE/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/E0892A43430A164AA0D1E041631E2BF933EB6DEE/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/E0892A43430A164AA0D1E041631E2BF933EB6DEE/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2009</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: CK was supported by Volkswagen Foundation, Hermann and Lilly Schilling Foundation, Deutsche Forschungsgemeinschaft DFG; SAS was supported by the Brain Research Trust, UK, a grant by the University Lübeck and the Novartis Foundation for Therapeutic Research. AEL: Grants: Canadian Institutes of Health Research, Dystonia Medical Research Foundation, Michael J. Fox Foundation, National Parkinson Foundation, Ontario Problem Gambling Reseach Centre, Parkinson's Disease Foundation, Taro.</note><note type="content">*This article is part of the journal's online CME program. The CME activity including form, can be found online at http://www.movementdisorders.org/education/journalcme/</note><note>Volkswagen Foundation</note><note>Career Development Award</note><note>Hermann and Lilly Schilling Foundation</note><note>Hermann and Lilly Schilling Foundation</note><note>Deutsche Forschungsgemeinschaft</note><note>University Lübeck and the Novartis Foundation for Therapeutic Research</note><note>Canadian Institutes of Health Research</note><note>Dystonia Medical Research Foundation</note><note>Michael J. Fox Foundation</note><note>National Parkinson Foundation</note><note>Ontario Problem Gambling Research Centre</note><note>Parkinson's Disease Foundation</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title><author><persName><forename type="first">Christine</forename><surname>Klein</surname></persName><roleName type="degree">MD</roleName><note type="correspondence"><p>Correspondence: Department of Neurology, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany</p></note><affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</affiliation><affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</affiliation></author><author><persName><forename type="first">Susanne A.</forename><surname>Schneider</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</affiliation><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</affiliation></author><author><persName><forename type="first">Anthony E.</forename><surname>Lang</surname></persName><roleName type="degree">MD, FRCPC</roleName><affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-10-30"></date><biblScope unit="volume">24</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2042">2042</biblScope><biblScope unit="page" to="2058">2058</biblScope></imprint></monogr><idno type="istex">E0892A43430A164AA0D1E041631E2BF933EB6DEE</idno><idno type="DOI">10.1002/mds.22675</idno><idno type="ArticleID">MDS22675</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson</term></item><item><term>PARK</term></item><item><term>genetics</term></item><item><term>dystonia</term></item><item><term>classification</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-01-06">Received</change><change when="2009-05-18">Registration</change><change when="2009-10-30">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/E0892A43430A164AA0D1E041631E2BF933EB6DEE/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="140"><doi origin="wiley" registered="yes">10.1002/mds.v24:14</doi><numberingGroup><numbering type="journalVolume" number="24">24</numbering><numbering type="journalIssue">14</numbering></numberingGroup><coverDate startDate="2009-10-30">30 October 2009</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="20" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22675</doi><idGroup><id type="unit" value="MDS22675"></id></idGroup><countGroup><count type="pageTotal" number="17"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2009 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2009-01-06"></event><event type="manuscriptRevised" date="2009-04-22"></event><event type="manuscriptAccepted" date="2009-05-18"></event><event type="publishedOnlineEarlyUnpaginated" date="2009-09-04"></event><event type="firstOnline" date="2009-09-04"></event><event type="publishedOnlineFinalForm" date="2009-10-28"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-21"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">2042</numbering><numbering type="pageLast">2058</numbering></numberingGroup><correspondenceTo>Department of Neurology, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22675.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="3"></count><count type="referenceTotal" number="186"></count><count type="wordTotal" number="11636"></count></countGroup><titleGroup><title type="main" xml:lang="en">Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “<i>PARK</i>” genes and beyond<link href="#fn1"></link> <link href="#fn2"></link></title><title type="short" xml:lang="en">Algorithm for Clinicians to “PARK” Genes</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2" corresponding="yes"><personName><givenNames>Christine</givenNames><familyName>Klein</familyName><degrees>MD</degrees></personName><contactDetails><email normalForm="christine.klein@neuro.uni-luebeck.de">christine.klein@neuro.uni‐luebeck.de</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1 #af3"><personName><givenNames>Susanne A.</givenNames><familyName>Schneider</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Anthony E.</givenNames><familyName>Lang</familyName><degrees>MD, FRCPC</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="CA" type="organization"><unparsedAffiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="GB" type="organization"><unparsedAffiliation>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson</keyword><keyword xml:id="kwd2"><i>PARK</i></keyword><keyword xml:id="kwd3">genetics</keyword><keyword xml:id="kwd4">dystonia</keyword><keyword xml:id="kwd5">classification</keyword></keywordGroup><fundingInfo><fundingAgency>Volkswagen Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Career Development Award</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Hermann and Lilly Schilling Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Hermann and Lilly Schilling Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Deutsche Forschungsgemeinschaft</fundingAgency></fundingInfo><fundingInfo><fundingAgency>University Lübeck and the Novartis Foundation for Therapeutic Research</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Canadian Institutes of Health Research</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Dystonia Medical Research Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Michael J. Fox Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>National Parkinson Foundation</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Ontario Problem Gambling Research Centre</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Parkinson's Disease Foundation</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous <i>GBA</i> mutations, mitochondrial gene mutations. Group III comprises mutations in the <i>FMR1</i>, <i>MAPT</i>, <i>GRN</i>, <i>ATP7B</i>, <i>PANK2</i>, <i>FBXO7</i>, <i>CHAC</i>, <i>FTL1</i>, <i>Huntingtin</i>, <i>JPH3</i> genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Potential conflict of interest: CK was supported by Volkswagen Foundation, Hermann and Lilly Schilling Foundation, Deutsche Forschungsgemeinschaft DFG; SAS was supported by the Brain Research Trust, UK, a grant by the University Lübeck and the Novartis Foundation for Therapeutic Research. AEL: Grants: Canadian Institutes of Health Research, Dystonia Medical Research Foundation, Michael J. Fox Foundation, National Parkinson Foundation, Ontario Problem Gambling Reseach Centre, Parkinson's Disease Foundation, Taro.</p></note><note xml:id="fn2"><p>This article is part of the journal's online CME program. The CME activity including form, can be found online at <url href="http://www.movementdisorders.org/education/journalcme/">http://www.movementdisorders.org/education/journalcme/</url></p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Algorithm for Clinicians to “PARK” Genes</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “</title></titleInfo><name type="personal"><namePart type="given">Christine</namePart><namePart type="family">Klein</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</affiliation><affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</affiliation><description>Correspondence: Department of Neurology, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Susanne A.</namePart><namePart type="family">Schneider</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, University of Lübeck, Lübeck, Germany</affiliation><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, UCL, Institute of Neurology, Queen Square, London, England</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anthony E.</namePart><namePart type="family">Lang</namePart><namePart type="termsOfAddress">MD, FRCPC</namePart><affiliation>Department of Neurology, Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2009-10-30</dateIssued><dateCaptured encoding="w3cdtf">2009-01-06</dateCaptured><dateValid encoding="w3cdtf">2009-05-18</dateValid><copyrightDate encoding="w3cdtf">2009</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">3</extent><extent unit="references">186</extent><extent unit="words">11636</extent></physicalDescription><abstract lang="en">In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well‐established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the “PARK” genes; (ii) classical parkinsonism due to mutations in “other than‐PARK” genes or yet other genes where parkinsonism may be a well‐recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions. © 2009 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: CK was supported by Volkswagen Foundation, Hermann and Lilly Schilling Foundation, Deutsche Forschungsgemeinschaft DFG; SAS was supported by the Brain Research Trust, UK, a grant by the University Lübeck and the Novartis Foundation for Therapeutic Research. AEL: Grants: Canadian Institutes of Health Research, Dystonia Medical Research Foundation, Michael J. Fox Foundation, National Parkinson Foundation, Ontario Problem Gambling Reseach Centre, Parkinson's Disease Foundation, Taro.</note><note type="content">*This article is part of the journal's online CME program. The CME activity including form, can be found online at http://www.movementdisorders.org/education/journalcme/</note><note type="funding">Volkswagen Foundation</note><note type="funding">Career Development Award</note><note type="funding">Hermann and Lilly Schilling Foundation</note><note type="funding">Hermann and Lilly Schilling Foundation</note><note type="funding">Deutsche Forschungsgemeinschaft</note><note type="funding">University Lübeck and the Novartis Foundation for Therapeutic Research</note><note type="funding">Canadian Institutes of Health Research</note><note type="funding">Dystonia Medical Research Foundation</note><note type="funding">Michael J. Fox Foundation</note><note type="funding">National Parkinson Foundation</note><note type="funding">Ontario Problem Gambling Research Centre</note><note type="funding">Parkinson's Disease Foundation</note><subject lang="en"><genre>Keywords</genre><topic>Parkinson</topic><topic>PARK</topic><topic>genetics</topic><topic>dystonia</topic><topic>classification</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><detail type="issue"><caption>no.</caption><number>14</number></detail><extent unit="pages"><start>2042</start><end>2058</end><total>17</total></extent></part></relatedItem><identifier type="istex">E0892A43430A164AA0D1E041631E2BF933EB6DEE</identifier><identifier type="DOI">10.1002/mds.22675</identifier><identifier type="ArticleID">MDS22675</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2009 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000247 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000247 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:E0892A43430A164AA0D1E041631E2BF933EB6DEE
|texte= Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond
}}
| This area was generated with Dilib version V0.6.23. |  |